Mark R. Munch Ph.D.
Net Worth
Last updated:
What is Mark R. Munch Ph.D. net worth?
The estimated net worth of Dr. Mark R. Munch Ph.D. is at least $17,337,698 as of 15 Dec 2021. He owns shares worth $2,900,682 as insider, has earned $7,486,676 from insider trading and has received compensation worth at least $6,950,340 in Bruker Corporation.
What is the salary of Mark R. Munch Ph.D.?
Dr. Mark R. Munch Ph.D. salary is $772,260 per year as Executive Vice President and Pres of Bruker Nano Group & Bruker Nano Surfaces Division in Bruker Corporation.
How old is Mark R. Munch Ph.D.?
Dr. Mark R. Munch Ph.D. is 63 years old, born in 1962.
What stocks does Mark R. Munch Ph.D. currently own?
As insider, Dr. Mark R. Munch Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bruker Corporation (BRKR) | Executive Vice President and Pres of Bruker Nano Group & Bruker Nano Surfaces Division | 85,064 | $34.1 | $2,900,682 |
What does Bruker Corporation do?
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Mark R. Munch Ph.D. insider trading
Bruker Corporation
Dr. Mark R. Munch Ph.D. has made 5 insider trades between 2016-2021, according to the Form 4 filled with the SEC. Most recently he sold 21,210 units of BRKR stock worth $1,685,644 on 15 Dec 2021.
The largest trade he's ever made was exercising 75,000 units of BRKR stock on 10 Mar 2016. As of 15 Dec 2021 he still owns at least 85,064 units of BRKR stock.
Bruker key executives
Bruker Corporation executives and other stock owners filed with the SEC:
- Dr. Falko Busse Ph.D. (58) Pres of Bruker BioSpin Group
- Dr. Frank H. Laukien Ph.D. (65) Chairman, Chief Executive Officer & Pres
- Dr. Mark R. Munch Ph.D. (63) Executive Vice President and Pres of Bruker Nano Group & Bruker Nano Surfaces Division
- Mr. Gerald N. Herman (67) Executive Vice President, Chief Financial Officer, Corporation Controller & Interim Head of IR
- Mr. Juergen Srega (70) Pres of Bruker CALID Group & Bruker Daltonics Division